Related Experiment Video
Updated: Jul 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53-Dependent p21 mRNA elongation is impaired when DNA replication is stalled
Melissa Mattia1, Vanesa Gottifredi, Kristine McKinney
1Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
Abstract:
We have previously reported that when DNA replication is blocked in some human cell lines, p53 is impaired in its ability to induce a subset of its key target genes, including p21(WAF1/CIP1). Here, we investigated the reason for this impairment by comparing the effects of two agents, hydroxyurea (HU), which arrests cells in early S phase and impairs induction of p21, and daunorubicin, which causes a G(2) block and leads to robust activation of p21 by p53. HU treatment was shown to inhibit p21 mRNA transcription rather than alter its mRNA stability. Nevertheless, chromatin immunoprecipitation assays revealed that HU impacts neither p53 binding nor acetylation of histones H3 and H4 within the p21 promoter. Furthermore, recruitment of the TFIID/TATA-binding protein complex and the large subunit of RNA polymerase II (RNA Pol II) are equivalent after HU and daunorubicin treatments. Relative to daunorubicin treatment, however, transcription elongation of the p21 gene is significantly impaired in cells treated with HU, as evidenced by reduced occupancy of RNA Pol II at regions downstream of the start site. Likewise, in the p21 downstream region after administration of HU, there is less of a specifically phosphorylated form of RNA Pol II (Pol II-C-terminal domain serine 2P) which occurs only when the polymerase is elongating RNA. We propose that while the DNA replication checkpoint is unlikely to regulate the assembly of a p21 promoter initiation complex, it signals to one or more factors involved in the process of transcriptional elongation.
Insights
Hydroxyurea (HU) impairs p21 gene induction by inhibiting transcription elongation, not initiation, in human cells. This suggests the DNA replication checkpoint affects elongation factors, not promoter complex assembly.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Gene Expression
Background:
- p53 is a key tumor suppressor protein that regulates genes involved in cell cycle arrest and apoptosis.
- p21(WAF1/CIP1) is a critical p53 target gene that inhibits cyclin-dependent kinases, promoting cell cycle arrest.
- Previous studies showed that blocking DNA replication impairs p53-mediated induction of some target genes, including p21.
Purpose of the Study:
- To investigate the molecular mechanism by which hydroxyurea (HU) impairs p53-mediated p21 induction.
- To compare the effects of HU (S phase arrest) and daunorubicin (G2 block) on p21 gene expression and p53 activity.
Main Methods:
- Cell culture and treatment with hydroxyurea (HU) or daunorubicin.
- Quantitative reverse transcription-PCR to measure p21 mRNA levels.
- Chromatin immunoprecipitation (ChIP) assays to assess p53 binding and histone modifications.
- ChIP assays to evaluate the recruitment of transcription initiation factors and RNA polymerase II (RNA Pol II).
- Analysis of RNA Pol II occupancy and phosphorylation at different gene regions.
Main Results:
- HU treatment inhibited p21 mRNA transcription, not mRNA stability.
- HU did not affect p53 binding or histone acetylation at the p21 promoter.
- Recruitment of TFIID/TATA-binding protein and RNA Pol II to the promoter was similar for HU and daunorubicin.
- HU significantly impaired transcription elongation of the p21 gene, indicated by reduced RNA Pol II occupancy downstream of the start site.
- HU treatment led to decreased levels of phosphorylated RNA Pol II (Ser2P) in the p21 gene's downstream region.
Conclusions:
- The DNA replication checkpoint, triggered by HU, does not impede the assembly of the p21 promoter initiation complex.
- The replication checkpoint likely signals to factors that regulate the process of transcriptional elongation for the p21 gene.
- Understanding these mechanisms is crucial for cancer therapy, as p53 and p21 are key players in tumor suppression.
Related Concept Videos
Restarting Stalled Replication Forks
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
The DNA Replication Fork

